ArticleBreast cancer (Tokyo, Japan)2023

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan.

K Nozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.